Action Against Cancer

Action Against Cancer Action Against Cancer funds the development of cures for cancer at Imperial College London, the University of Sussex and Anglia Ruskin University Cambridge.

Much of this work is led by world-renowned oncologist, Professor Justin Stebbing. Action Against Cancer funds the development of cures for cancer at Imperial College, Hammersmith Hospital, led by world-renowned oncologist, Professor Justin Stebbing. The groundbreaking programmes that we fund focus on developing new diagnostics and treatments to improve the survival prospects and quality of life for millions of cancer sufferers worldwide.

In this article, Professor Stebbing explains a new study showing the remarkable success of the HPV vaccine. Between 2020...
25/06/2026

In this article, Professor Stebbing explains a new study showing the remarkable success of the HPV vaccine. Between 2020 and 2024, no woman in England aged 20 to 24 – who had been vaccinated as a teenager – died from cervical cancer. Hundreds of deaths have already been prevented, and many more lives are likely to be saved.

No vaccinated young woman in England has died of cervical cancer in years. Japan’s vaccine scare shows how easily that progress can unravel.

Massive thanks to Jason Bone for organizing the amazing Let’s HIIT Cancer event at the weekend in support of our work! A...
22/06/2026

Massive thanks to Jason Bone for organizing the amazing Let’s HIIT Cancer event at the weekend in support of our work! And huge thanks to everyone who took part in the exercise sessions in Battersea Park. The fundraising page is still live, please donate if you can: https://givestar.io/gs/lets-hiit-cancer

We have partnered with Ultra Events, so now you can fundraise for our work whilst getting 8 weeks of free training in co...
19/06/2026

We have partnered with Ultra Events, so now you can fundraise for our work whilst getting 8 weeks of free training in comedy, boxing or MMA and take part in incredible events! Click the links in the comments to sign up!

In this article Professor Stebbing outlines a quiet revolution in radiotherapy for prostate cancer patients, with fewer ...
16/06/2026

In this article Professor Stebbing outlines a quiet revolution in radiotherapy for prostate cancer patients, with fewer journeys to hospital, and a treatment that tries to hit the cancer harder while hitting the rest of the body a little less.

The treatment is shorter and more convenient, but it will not suit every man with prostate cancer.

This article by Professor Stebbing explains the gene test that helps protect high risk patients who need chemotherapy, a...
04/06/2026

This article by Professor Stebbing explains the gene test that helps protect high risk patients who need chemotherapy, and protects low risk patients from being overtreated.

A new DNA test could spare millions of breast cancer patients from chemotherapy. We answer your questions about what it means and who it helps.

In this new piece in The Independent, Professor Stebbing explains that the role of vitamin D in colorectal cancer is pro...
06/05/2026

In this new piece in The Independent, Professor Stebbing explains that the role of vitamin D in colorectal cancer is promising. “While it’s not time to rely on supplements alone, ensuring adequate vitamin D levels – through sun exposure, diet, or supplements – remains a smart choice for your health.”

Its role in the health sphere is promising, writes Justin Stebbing for The Conversation

In the UK, the overall number of cancers in people aged roughly 25 to 49 has risen by around a quarter since the early 1...
01/05/2026

In the UK, the overall number of cancers in people aged roughly 25 to 49 has risen by around a quarter since the early 1990s, even after accounting for population growth. In this article, Professor Stebbing explains more from a new analysis.

Breast, bowel, kidney, pancreatic and ovarian cancer were among the types of cancer found to be increasing in people aged 25 to 49.

We are proud to have funded a significant breakthrough for brain cancer patients, just published in a highly respected s...
28/04/2026

We are proud to have funded a significant breakthrough for brain cancer patients, just published in a highly respected scientific journal. A team at the University of Sussex have identified a blood test capable of early diagnosis of the most aggressive form of brain tumour, replacing the need for risky brain surgery. https://aacancer.org/newsandevents/breakthrough-brain-tumour-blood-test.html.php

A fascinating article written by Professor Stebbing with findings from a new large study showing that people who have be...
14/04/2026

A fascinating article written by Professor Stebbing with findings from a new large study showing that people who have been married seem less likely to develop cancer than those who have never married at all.

A large new study finds unmarried adults face significantly higher cancer rates, but the real story is about what marriage represents, not what it does.

Another interesting article published by Professor Stebbing, this time with a finding that could change how men with pro...
07/04/2026

Another interesting article published by Professor Stebbing, this time with a finding that could change how men with prostate cancer that has spread beyond the gland are treated for years to come – with HRT patches.

Women’s HRT patches control prostate cancer as well as standard hormone injections, but with fewer hot flushes and less bone loss, a major UK trial finds.

Address

Regency Chambers
Manchester
BL90JW

Alerts

Be the first to know and let us send you an email when Action Against Cancer posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share